Results of a long-term study in hormone replacement therapy with Klimonorm®

Drugs of Today

Volumn 37, Issue SUPPL. C, 2001, Pages 23-29

  Burdova M ^a   Kancheva, R ^a   Hill, M ^a  

^a Private Pneumological Practice   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; ESTRADIOL VALERATE PLUS NORGESTREL; ESTROGEN; GESTAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; ENDOMETRIUM; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034943634     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Current perspectives on the benefits of HRT in menopausal women
2. Osteoporosis: Prevention with estrogens in women over 60
3. Lipid profile during hormone replacement therapy: Effect of different progestins?
4. Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy
5. Strategies for effectively addressing women's concerns about the menopause and HRT
6. HRT and cancer risk: Separating fact from fiction
7. Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
8. Recent insights into the varying activity of estrogens
9. Hormonal replacement regimens and bleeding
10. Dienogest as a progestin for hormone replacement therapy
11. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use
12. Multicenter study of Klimonorm® by the Jenapharm firm for treating the climacteric syndrome
13. Low-potency oestrogen and risk of endometrial cancer: A case-control study
14. Hormonal replacement therapy and endometrial cancer risk: A meta-analysis
15. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women
16. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives
17. Desogestrel in hormone replacement therapy: Long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding
18. Disorders of lipid metabolism
19. Effect of postmenopausal estrogen replacement therapy on lipoproteins
20. Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins
21. Serum lipids in Chinese patients using oral contraceptive pills
22. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2
23. Lipid metabolism in Norplant-2 users - A two-year follow-up study. Total cholesterol, triglycerides, lipoproteins and apolipoproteins
24. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women
25. Estrogen and coronary heart disease in women